However, the most significant changes in body weight generally occur after several months of consistent use
Association of glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: a meta-analysis of randomized controlled trials
The function of this type of medication is to control glucose levels, reduce appetite, and give the feeling of satiety
Theory 2: GLP-1 is a miraculous moderation molecule, and it has docking portals all throughout the body that reduce inflammation
When activated, GLP-1R slows gastric emptying, reduces glucagon secretion, reduces appetite through central mechanisms, and reduces cardiovascular risk through pathways that are still being elucidated
Glucagon-Like Peptide-1 Receptor Agonists (StatPearls Publishing, 2024)